This inventor holds 2 USPTO granted patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Yong Liu: Innovator in Pharmaceutical Research
Introduction
Yong Liu is a prominent inventor based in Princeton, NJ (US), known for his contributions to pharmaceutical research. He holds 2 patents that focus on innovative treatments for viral infections and neurodegenerative diseases. His work has significant implications for the development of new therapies.
Latest Patents
Yong Liu's latest patents include "Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof." This invention relates to novel pseudopolymorphs of Compound A, which are useful for treating or preventing HCV infection in patients. Another notable patent is "Crystalline forms of a BACE inhibitor, compositions, and their use." This patent provides four crystalline forms of verubecestat, which may be beneficial in treating Alzheimer's disease and other Aβ pathologies.
Career Highlights
Yong Liu is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for complex diseases.
Collaborations
Yong Liu collaborates with talented colleagues, including Scott Trzaska and Zachary E Dance, to enhance the impact of his research and innovations.
Conclusion
Yong Liu's contributions to pharmaceutical research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile